HYPOMETHYLATING AGENTS IN MYELODYSPLASTIC SYNDROME-SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Gurion, R. [1 ]
Vidal, L. [1 ]
Gafter-Gvili, A. [1 ]
Belnik, Y. [1 ]
Yeshurun, M. [1 ]
Raanani, P. [1 ]
Shpilberg, O. [1 ]
机构：
[1] Rabin Med Ctr, Petah Tiqwa, Israel
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0261
引用
收藏
页码：104 / 104
页数：1
相关论文
共 50 条
  • [1] Hypomethylating agents for patients with myelodysplastic syndrome: a systematic review with meta-analysis
    Bauer, K.
    Hutzschenreuter, F.
    Skoetz, N.
    Monsef, I
    Kreuzer, K. -A
    Engert, A.
    ONKOLOGIE, 2012, 35 : 31 - 31
  • [2] Outcomes after venetoclax with hypomethylating agents in myelodysplastic syndromes: a systematic review and meta-analysis
    Khanam, Razwana
    Shahzad, Moazzam
    Chaudhary, Sibgha Gull
    Ali, Fatima
    Shah, Zunairah
    Pachika, Pranali S.
    Ahmed, Zahoor
    Chattaraj, Asmi
    Masood, Adeel
    Ahmed, Nausheen
    Bansal, Rajat
    Balusu, Ramesh
    Shune, Leyla
    Anwar, Faiz
    Hematti, Peiman
    McGuirk, Joseph P.
    Yacoub, Abdulraheem
    Mushtaq, Muhammad Umair
    LEUKEMIA & LYMPHOMA, 2022, 63 (11) : 2671 - 2678
  • [3] Meta-analysis on hypomethylating agents in myelodysplastic syndromes
    Herbst, Christine
    Baner, Kathrin
    Kreuzer, Karl-Anton
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (02): : 342 - 343
  • [4] THE IMPACT OF AZACITIDINE AND DECITABINE (HYPOMETHYLATING-AGENTS) IN MYELODYSPLASTIC SYNDROMES: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Kumar, A.
    List, F.
    Hozo, I.
    Djulbegovic, B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 269 - 270
  • [5] Methadone dose and neonatal abstinence syndrome-systematic review and meta-analysis
    Cleary, Brian J.
    Donnelly, Jean
    Strawbridge, Judith
    Gallagher, Paul J.
    Fahey, Tom
    Clarke, Mike
    Murphy, Deirdre J.
    ADDICTION, 2010, 105 (12) : 2071 - 2084
  • [6] Maintenance With Hypomethylating Agents After Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Systematic Review and Meta-Analysis
    Kungwankiattichai, Smith
    Ponvilawan, Ben
    Roy, Claudie
    Tunsing, Pattaraporn
    Kuchenbauer, Florian
    Owattanapanich, Weerapat
    FRONTIERS IN MEDICINE, 2022, 9
  • [7] Hypomethylating agents for patients with myelodysplastic syndromes prior to hematopoietic stem cell transplantation: a systematic review and meta-analysis
    Qin, Yao
    Kuang, Pu
    Zeng, Qiang
    Wu, Yuling
    Liu, Ting
    ANNALS OF HEMATOLOGY, 2019, 98 (11) : 2523 - 2531
  • [8] Hypomethylating agents for patients with myelodysplastic syndromes prior to hematopoietic stem cell transplantation: a systematic review and meta-analysis
    Yao Qin
    Pu Kuang
    Qiang Zeng
    Yuling Wu
    Ting Liu
    Annals of Hematology, 2019, 98 : 2523 - 2531
  • [9] Commentary: Maintenance with hypomethylating agents after allogeneic stem cell transplantation in acute myeloid leukemia and myelodysplastic syndrome: A systematic review and meta-analysis
    Beauvais, David
    Wattebled, Kevin-James
    Drumez, Elodie
    Yakoub-Agha, Ibrahim
    FRONTIERS IN MEDICINE, 2022, 9
  • [10] The efficacy and adverse events of venetoclax in combination with hypomethylating agents treatment for patients with acute myeloid leukemia and myelodysplastic syndrome: a systematic review and meta-analysis
    Liu, Bei
    Guo, Yuancheng
    Deng, Lijuan
    Qiao, Yanhong
    Jian, Jinli
    HEMATOLOGY, 2020, 25 (01) : 414 - 423
12345